Profile	GDS3514 / 218966_at
Title	Liposarcoma response to doxorubicin in vitro
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM325240	Patient no. 1: control	574.004	61
GSM325241	Patient no. 1: treated	675.572	64
GSM325242	Patient no. 9: control	888.53	73
GSM325243	Patient no. 9: treated	728.772	69
GSM325244	Patient no. 18: control	890.023	70
GSM325245	Patient no. 18: treated	790.549	68
GSM325246	Patient no. 12: control	474.941	61
GSM325247	Patient no. 12: treated	381.699	58
GSM325248	Patient no. 3: control	426.404	56
GSM325249	Patient no. 3: treated	414.585	56
GSM325250	Patient no. 7: control	320.516	53
GSM325251	Patient no. 7: treated	246.591	49
GSM325252	Patient no. 15: control	743.003	67
GSM325253	Patient no. 15: treated	623.531	63
GSM325254	Patient no. 4: control	1050.44	74
GSM325255	Patient no. 4: treated	1227.08	77
GSM325256	Patient no. 19: control	487.574	61
GSM325257	Patient no. 19: treated	397.734	57
GSM325258	Patient no. 14: control	531.854	60
GSM325259	Patient no. 14: treated	638.406	63
GSM325260	Patient no. 13: control	561.944	60
GSM325261	Patient no. 13: treated	776.353	67
GSM325262	Patient no. 17: control	665.159	63
GSM325263	Patient no. 17: treated	436.601	55
GSM325264	Patient no. 10: control	401.672	55
GSM325265	Patient no. 10: treated	382.275	53
GSM325266	Patient no. 5: control	395.031	55
GSM325267	Patient no. 5: treated	167.788	44
GSM325268	Patient no. 11: control	816.367	68
GSM325269	Patient no. 11: treated	431.511	58
GSM325270	Patient no. 6: control	1656.56	83
GSM325271	Patient no. 6: treated	491.896	61
GSM325272	Patient no. 8: control	1398.53	80
GSM325273	Patient no. 8: treated	982.384	74
GSM325274	Patient no. 16: control	533.793	59
GSM325275	Patient no. 16: treated	418.001	57
GSM325276	Patient no. 2: control	1201.79	75
GSM325277	Patient no. 2: treated	436.179	60